drugset / Trial / NCT05375305

A Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery

NCT05375305

Phase 2/3 Completed 320 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to evaluate the analgesic efficacy of IV SHR8554 compared with morphine and placebo in patients with acute postoperative pain following orthopedic surgery.

Timeline

Start
2022-05-11
Primary completion
2023-10-19
Completion
2023-10-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified
Subject SHR8554 Unknown Intravenous

Indications

No indication recorded.